Study of Safety, Tolerability and Efficacy of MK0493 in Obese Patients (0493-008)(COMPLETED)
This study has been completed.
Information provided by:
First received: June 1, 2007
Last updated: May 20, 2013
Last verified: May 2013
To assess the effect of MK0493 on body weight, blood pressure, mood, and appetite.
|Study Design:||Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
Resource links provided by NLM:
Further study details as provided by Merck:
Contacts and Locations